Log in to save to my catalogue

Seizure activity and anion gap metabolic acidosis secondary to adverse effect of nalidixic acid—a ca...

Seizure activity and anion gap metabolic acidosis secondary to adverse effect of nalidixic acid—a ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7805518

Seizure activity and anion gap metabolic acidosis secondary to adverse effect of nalidixic acid—a case report

About this item

Full title

Seizure activity and anion gap metabolic acidosis secondary to adverse effect of nalidixic acid—a case report

Publisher

England: Oxford University Press

Journal title

Oxford Medical Case Reports, 2021-01, Vol.2021 (1), p.omaa120

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Nalidixic acid is a commonly prescribed treatment for suspected dysentery in Middle Eastern populations. We describe a case of convulsions resulting from a single dose of nalidixic acid in a previously healthy two-month-old child in Northern Iraq who was being treated for a diarrhoeal illness. The child presented to us with new onset se...

Alternative Titles

Full title

Seizure activity and anion gap metabolic acidosis secondary to adverse effect of nalidixic acid—a case report

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7805518

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7805518

Other Identifiers

ISSN

2053-8855

E-ISSN

2053-8855

DOI

10.1093/omcr/omaa120

How to access this item